The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Discovery Biosimulation Software Market Research Report 2025
Synopsis
The global market for Drug Discovery Biosimulation Software was valued at US$ 1020 million in the year 2024 and is projected to reach a revised size of US$ 2124 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Drug discovery biosimulation software refers to a professional software tool that uses computer modeling, mathematical algorithms, and bioinformatics techniques to simulate and predict the interactions between drug molecules and biological systems (such as proteins, cells, tissues, or the entire organism). This type of software can predict the pharmacological activity, toxicity, and pharmacokinetic properties of candidate compounds in a virtual environment by establishing quantitative structure-activity relationships (QSAR), molecular dynamics simulations, systems biology models, and other methods, thereby significantly reducing the laboratory testing and animal experiments required in traditional drug discovery processes.
The global market for biosimulation software for drug discovery has shown a steady growth trend in recent years. Biological simulation technology can help pharmaceutical companies reduce research and development costs and shorten research and development cycles. The cost-benefit ratio is particularly important in the context of patent cliff and medical expenditure control. Regulatory agencies such as the US FDA and European EMA are increasingly accepting modeling and simulation data as auxiliary evidence for new drug applications. The integration of artificial intelligence algorithms, high-performance computing, and biological big data analysis has significantly improved the predictive accuracy and applicability of biological simulations, making them gradually become one of the core methods for drug discovery from auxiliary tools. The rise of precision medicine and personalized dosing regimens has increased the demand for patient specific simulations, driving the expansion of the application of biosimulation software in preclinical and clinical stages. North America currently holds the largest market share, followed by Europe and the Asia Pacific region. The market presents a diversified competitive pattern and moderate concentration characteristics. The main participants include well-known companies such as Biolauncher, Certara, Dassault Systemes, etc. Leading companies mainly maintain and expand their market position through technological innovation, strategic mergers and acquisitions, partnerships, and cloud service transformation. In the Chinese market, core technologies and high-end markets are still dominated by international giants, but local enterprises such as Tencent AI Lab and PharmaResources are gradually increasing their influence through independent research and development and strategic cooperation. In the future, the integration of artificial intelligence will become the most significant trend in technological development. The new generation of AI driven simulation tools can learn complex patterns from massive biomedical data and achieve higher precision predictions. The next generation of biological simulation software will have the ability to integrate and analyze multidimensional data such as genomics, proteomics, metabolomics, etc., and construct multi-scale models that are closer to real biological systems.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Biosimulation Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Biosimulation Software.
The Drug Discovery Biosimulation Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery Biosimulation Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Biosimulation Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biolauncher
Pfizer
Dassault Systemes
Novartis
Schrodinger
AstraZeneca
Insilico Medicine
Simulations Plus
Molecular Networks
Evotec
Boehringer Ingelheim
Certara
Tencent AI Lab
PharmaResources
Quantum Hi-Tech (China) Biotechnology
Leto Laboratories
Zuoshouyisheng
Taimei Technology
AIxplorerbio
Moore Threads
StoneWise
NovaX Biotech
Segment by Type
Molecular Modeling And Structural Prediction Software
Virtual Screening And Molecular Design Software
ADMET Prediction Software
Molecular Dynamics Simulation Software
Systems Biology And Multiscale Modeling Software
Others
Segment by Application
Target Recognition
Virtual Screening
Lead Optimization
Pharmacokinetic Simulation
Toxic Predicting
Mechanism Analysis
Effect Analysis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Biosimulation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Drug Discovery Biosimulation Software was valued at US$ 1020 million in the year 2024 and is projected to reach a revised size of US$ 2124 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Drug discovery biosimulation software refers to a professional software tool that uses computer modeling, mathematical algorithms, and bioinformatics techniques to simulate and predict the interactions between drug molecules and biological systems (such as proteins, cells, tissues, or the entire organism). This type of software can predict the pharmacological activity, toxicity, and pharmacokinetic properties of candidate compounds in a virtual environment by establishing quantitative structure-activity relationships (QSAR), molecular dynamics simulations, systems biology models, and other methods, thereby significantly reducing the laboratory testing and animal experiments required in traditional drug discovery processes.
The global market for biosimulation software for drug discovery has shown a steady growth trend in recent years. Biological simulation technology can help pharmaceutical companies reduce research and development costs and shorten research and development cycles. The cost-benefit ratio is particularly important in the context of patent cliff and medical expenditure control. Regulatory agencies such as the US FDA and European EMA are increasingly accepting modeling and simulation data as auxiliary evidence for new drug applications. The integration of artificial intelligence algorithms, high-performance computing, and biological big data analysis has significantly improved the predictive accuracy and applicability of biological simulations, making them gradually become one of the core methods for drug discovery from auxiliary tools. The rise of precision medicine and personalized dosing regimens has increased the demand for patient specific simulations, driving the expansion of the application of biosimulation software in preclinical and clinical stages. North America currently holds the largest market share, followed by Europe and the Asia Pacific region. The market presents a diversified competitive pattern and moderate concentration characteristics. The main participants include well-known companies such as Biolauncher, Certara, Dassault Systemes, etc. Leading companies mainly maintain and expand their market position through technological innovation, strategic mergers and acquisitions, partnerships, and cloud service transformation. In the Chinese market, core technologies and high-end markets are still dominated by international giants, but local enterprises such as Tencent AI Lab and PharmaResources are gradually increasing their influence through independent research and development and strategic cooperation. In the future, the integration of artificial intelligence will become the most significant trend in technological development. The new generation of AI driven simulation tools can learn complex patterns from massive biomedical data and achieve higher precision predictions. The next generation of biological simulation software will have the ability to integrate and analyze multidimensional data such as genomics, proteomics, metabolomics, etc., and construct multi-scale models that are closer to real biological systems.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Biosimulation Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Biosimulation Software.
The Drug Discovery Biosimulation Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery Biosimulation Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Biosimulation Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biolauncher
Pfizer
Dassault Systemes
Novartis
Schrodinger
AstraZeneca
Insilico Medicine
Simulations Plus
Molecular Networks
Evotec
Boehringer Ingelheim
Certara
Tencent AI Lab
PharmaResources
Quantum Hi-Tech (China) Biotechnology
Leto Laboratories
Zuoshouyisheng
Taimei Technology
AIxplorerbio
Moore Threads
StoneWise
NovaX Biotech
Segment by Type
Molecular Modeling And Structural Prediction Software
Virtual Screening And Molecular Design Software
ADMET Prediction Software
Molecular Dynamics Simulation Software
Systems Biology And Multiscale Modeling Software
Others
Segment by Application
Target Recognition
Virtual Screening
Lead Optimization
Pharmacokinetic Simulation
Toxic Predicting
Mechanism Analysis
Effect Analysis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Biosimulation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Biosimulation Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Modeling And Structural Prediction Software
1.2.3 Virtual Screening And Molecular Design Software
1.2.4 ADMET Prediction Software
1.2.5 Molecular Dynamics Simulation Software
1.2.6 Systems Biology And Multiscale Modeling Software
1.2.7 Others
1.3 Market by Application
1.3.1 Global Drug Discovery Biosimulation Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Target Recognition
1.3.3 Virtual Screening
1.3.4 Lead Optimization
1.3.5 Pharmacokinetic Simulation
1.3.6 Toxic Predicting
1.3.7 Mechanism Analysis
1.3.8 Effect Analysis
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Biosimulation Software Market Perspective (2020-2031)
2.2 Global Drug Discovery Biosimulation Software Growth Trends by Region
2.2.1 Global Drug Discovery Biosimulation Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery Biosimulation Software Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery Biosimulation Software Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery Biosimulation Software Market Dynamics
2.3.1 Drug Discovery Biosimulation Software Industry Trends
2.3.2 Drug Discovery Biosimulation Software Market Drivers
2.3.3 Drug Discovery Biosimulation Software Market Challenges
2.3.4 Drug Discovery Biosimulation Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Biosimulation Software Players by Revenue
3.1.1 Global Top Drug Discovery Biosimulation Software Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery Biosimulation Software Revenue Market Share by Players (2020-2025)
3.2 Global Top Drug Discovery Biosimulation Software Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery Biosimulation Software Revenue
3.4 Global Drug Discovery Biosimulation Software Market Concentration Ratio
3.4.1 Global Drug Discovery Biosimulation Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Biosimulation Software Revenue in 2024
3.5 Global Key Players of Drug Discovery Biosimulation Software Head office and Area Served
3.6 Global Key Players of Drug Discovery Biosimulation Software, Product and Application
3.7 Global Key Players of Drug Discovery Biosimulation Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Biosimulation Software Breakdown Data by Type
4.1 Global Drug Discovery Biosimulation Software Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Type (2026-2031)
5 Drug Discovery Biosimulation Software Breakdown Data by Application
5.1 Global Drug Discovery Biosimulation Software Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery Biosimulation Software Market Size (2020-2031)
6.2 North America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
6.4 North America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Biosimulation Software Market Size (2020-2031)
7.2 Europe Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
7.4 Europe Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Biosimulation Software Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery Biosimulation Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Biosimulation Software Market Size (2020-2031)
9.2 Latin America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Biosimulation Software Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biolauncher
11.1.1 Biolauncher Company Details
11.1.2 Biolauncher Business Overview
11.1.3 Biolauncher Drug Discovery Biosimulation Software Introduction
11.1.4 Biolauncher Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.1.5 Biolauncher Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Discovery Biosimulation Software Introduction
11.2.4 Pfizer Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Dassault Systemes
11.3.1 Dassault Systemes Company Details
11.3.2 Dassault Systemes Business Overview
11.3.3 Dassault Systemes Drug Discovery Biosimulation Software Introduction
11.3.4 Dassault Systemes Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.3.5 Dassault Systemes Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Discovery Biosimulation Software Introduction
11.4.4 Novartis Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Details
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Drug Discovery Biosimulation Software Introduction
11.5.4 Schrodinger Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.5.5 Schrodinger Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Drug Discovery Biosimulation Software Introduction
11.6.4 AstraZeneca Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Details
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Discovery Biosimulation Software Introduction
11.7.4 Insilico Medicine Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.7.5 Insilico Medicine Recent Development
11.8 Simulations Plus
11.8.1 Simulations Plus Company Details
11.8.2 Simulations Plus Business Overview
11.8.3 Simulations Plus Drug Discovery Biosimulation Software Introduction
11.8.4 Simulations Plus Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.8.5 Simulations Plus Recent Development
11.9 Molecular Networks
11.9.1 Molecular Networks Company Details
11.9.2 Molecular Networks Business Overview
11.9.3 Molecular Networks Drug Discovery Biosimulation Software Introduction
11.9.4 Molecular Networks Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.9.5 Molecular Networks Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec Drug Discovery Biosimulation Software Introduction
11.10.4 Evotec Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.10.5 Evotec Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Drug Discovery Biosimulation Software Introduction
11.11.4 Boehringer Ingelheim Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Certara
11.12.1 Certara Company Details
11.12.2 Certara Business Overview
11.12.3 Certara Drug Discovery Biosimulation Software Introduction
11.12.4 Certara Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.12.5 Certara Recent Development
11.13 Tencent AI Lab
11.13.1 Tencent AI Lab Company Details
11.13.2 Tencent AI Lab Business Overview
11.13.3 Tencent AI Lab Drug Discovery Biosimulation Software Introduction
11.13.4 Tencent AI Lab Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.13.5 Tencent AI Lab Recent Development
11.14 PharmaResources
11.14.1 PharmaResources Company Details
11.14.2 PharmaResources Business Overview
11.14.3 PharmaResources Drug Discovery Biosimulation Software Introduction
11.14.4 PharmaResources Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.14.5 PharmaResources Recent Development
11.15 Quantum Hi-Tech (China) Biotechnology
11.15.1 Quantum Hi-Tech (China) Biotechnology Company Details
11.15.2 Quantum Hi-Tech (China) Biotechnology Business Overview
11.15.3 Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Introduction
11.15.4 Quantum Hi-Tech (China) Biotechnology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.15.5 Quantum Hi-Tech (China) Biotechnology Recent Development
11.16 Leto Laboratories
11.16.1 Leto Laboratories Company Details
11.16.2 Leto Laboratories Business Overview
11.16.3 Leto Laboratories Drug Discovery Biosimulation Software Introduction
11.16.4 Leto Laboratories Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.16.5 Leto Laboratories Recent Development
11.17 Zuoshouyisheng
11.17.1 Zuoshouyisheng Company Details
11.17.2 Zuoshouyisheng Business Overview
11.17.3 Zuoshouyisheng Drug Discovery Biosimulation Software Introduction
11.17.4 Zuoshouyisheng Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.17.5 Zuoshouyisheng Recent Development
11.18 Taimei Technology
11.18.1 Taimei Technology Company Details
11.18.2 Taimei Technology Business Overview
11.18.3 Taimei Technology Drug Discovery Biosimulation Software Introduction
11.18.4 Taimei Technology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.18.5 Taimei Technology Recent Development
11.19 AIxplorerbio
11.19.1 AIxplorerbio Company Details
11.19.2 AIxplorerbio Business Overview
11.19.3 AIxplorerbio Drug Discovery Biosimulation Software Introduction
11.19.4 AIxplorerbio Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.19.5 AIxplorerbio Recent Development
11.20 Moore Threads
11.20.1 Moore Threads Company Details
11.20.2 Moore Threads Business Overview
11.20.3 Moore Threads Drug Discovery Biosimulation Software Introduction
11.20.4 Moore Threads Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.20.5 Moore Threads Recent Development
11.21 StoneWise
11.21.1 StoneWise Company Details
11.21.2 StoneWise Business Overview
11.21.3 StoneWise Drug Discovery Biosimulation Software Introduction
11.21.4 StoneWise Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.21.5 StoneWise Recent Development
11.22 NovaX Biotech
11.22.1 NovaX Biotech Company Details
11.22.2 NovaX Biotech Business Overview
11.22.3 NovaX Biotech Drug Discovery Biosimulation Software Introduction
11.22.4 NovaX Biotech Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.22.5 NovaX Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Discovery Biosimulation Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Modeling And Structural Prediction Software
Table 3. Key Players of Virtual Screening And Molecular Design Software
Table 4. Key Players of ADMET Prediction Software
Table 5. Key Players of Molecular Dynamics Simulation Software
Table 6. Key Players of Systems Biology And Multiscale Modeling Software
Table 7. Key Players of Others
Table 8. Global Drug Discovery Biosimulation Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Drug Discovery Biosimulation Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Drug Discovery Biosimulation Software Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Drug Discovery Biosimulation Software Market Share by Region (2020-2025)
Table 12. Global Drug Discovery Biosimulation Software Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Drug Discovery Biosimulation Software Market Share by Region (2026-2031)
Table 14. Drug Discovery Biosimulation Software Market Trends
Table 15. Drug Discovery Biosimulation Software Market Drivers
Table 16. Drug Discovery Biosimulation Software Market Challenges
Table 17. Drug Discovery Biosimulation Software Market Restraints
Table 18. Global Drug Discovery Biosimulation Software Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drug Discovery Biosimulation Software Market Share by Players (2020-2025)
Table 20. Global Top Drug Discovery Biosimulation Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Biosimulation Software as of 2024)
Table 21. Ranking of Global Top Drug Discovery Biosimulation Software Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drug Discovery Biosimulation Software Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drug Discovery Biosimulation Software, Headquarters and Area Served
Table 24. Global Key Players of Drug Discovery Biosimulation Software, Product and Application
Table 25. Global Key Players of Drug Discovery Biosimulation Software, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drug Discovery Biosimulation Software Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Drug Discovery Biosimulation Software Revenue Market Share by Type (2020-2025)
Table 29. Global Drug Discovery Biosimulation Software Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Drug Discovery Biosimulation Software Revenue Market Share by Type (2026-2031)
Table 31. Global Drug Discovery Biosimulation Software Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Drug Discovery Biosimulation Software Revenue Market Share by Application (2020-2025)
Table 33. Global Drug Discovery Biosimulation Software Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Drug Discovery Biosimulation Software Revenue Market Share by Application (2026-2031)
Table 35. North America Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Drug Discovery Biosimulation Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)
Table 50. Biolauncher Company Details
Table 51. Biolauncher Business Overview
Table 52. Biolauncher Drug Discovery Biosimulation Software Product
Table 53. Biolauncher Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 54. Biolauncher Recent Development
Table 55. Pfizer Company Details
Table 56. Pfizer Business Overview
Table 57. Pfizer Drug Discovery Biosimulation Software Product
Table 58. Pfizer Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 59. Pfizer Recent Development
Table 60. Dassault Systemes Company Details
Table 61. Dassault Systemes Business Overview
Table 62. Dassault Systemes Drug Discovery Biosimulation Software Product
Table 63. Dassault Systemes Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 64. Dassault Systemes Recent Development
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Drug Discovery Biosimulation Software Product
Table 68. Novartis Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Schrodinger Company Details
Table 71. Schrodinger Business Overview
Table 72. Schrodinger Drug Discovery Biosimulation Software Product
Table 73. Schrodinger Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 74. Schrodinger Recent Development
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Drug Discovery Biosimulation Software Product
Table 78. AstraZeneca Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 79. AstraZeneca Recent Development
Table 80. Insilico Medicine Company Details
Table 81. Insilico Medicine Business Overview
Table 82. Insilico Medicine Drug Discovery Biosimulation Software Product
Table 83. Insilico Medicine Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 84. Insilico Medicine Recent Development
Table 85. Simulations Plus Company Details
Table 86. Simulations Plus Business Overview
Table 87. Simulations Plus Drug Discovery Biosimulation Software Product
Table 88. Simulations Plus Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 89. Simulations Plus Recent Development
Table 90. Molecular Networks Company Details
Table 91. Molecular Networks Business Overview
Table 92. Molecular Networks Drug Discovery Biosimulation Software Product
Table 93. Molecular Networks Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 94. Molecular Networks Recent Development
Table 95. Evotec Company Details
Table 96. Evotec Business Overview
Table 97. Evotec Drug Discovery Biosimulation Software Product
Table 98. Evotec Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 99. Evotec Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Drug Discovery Biosimulation Software Product
Table 103. Boehringer Ingelheim Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Certara Company Details
Table 106. Certara Business Overview
Table 107. Certara Drug Discovery Biosimulation Software Product
Table 108. Certara Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 109. Certara Recent Development
Table 110. Tencent AI Lab Company Details
Table 111. Tencent AI Lab Business Overview
Table 112. Tencent AI Lab Drug Discovery Biosimulation Software Product
Table 113. Tencent AI Lab Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 114. Tencent AI Lab Recent Development
Table 115. PharmaResources Company Details
Table 116. PharmaResources Business Overview
Table 117. PharmaResources Drug Discovery Biosimulation Software Product
Table 118. PharmaResources Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 119. PharmaResources Recent Development
Table 120. Quantum Hi-Tech (China) Biotechnology Company Details
Table 121. Quantum Hi-Tech (China) Biotechnology Business Overview
Table 122. Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Product
Table 123. Quantum Hi-Tech (China) Biotechnology Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 124. Quantum Hi-Tech (China) Biotechnology Recent Development
Table 125. Leto Laboratories Company Details
Table 126. Leto Laboratories Business Overview
Table 127. Leto Laboratories Drug Discovery Biosimulation Software Product
Table 128. Leto Laboratories Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 129. Leto Laboratories Recent Development
Table 130. Zuoshouyisheng Company Details
Table 131. Zuoshouyisheng Business Overview
Table 132. Zuoshouyisheng Drug Discovery Biosimulation Software Product
Table 133. Zuoshouyisheng Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 134. Zuoshouyisheng Recent Development
Table 135. Taimei Technology Company Details
Table 136. Taimei Technology Business Overview
Table 137. Taimei Technology Drug Discovery Biosimulation Software Product
Table 138. Taimei Technology Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 139. Taimei Technology Recent Development
Table 140. AIxplorerbio Company Details
Table 141. AIxplorerbio Business Overview
Table 142. AIxplorerbio Drug Discovery Biosimulation Software Product
Table 143. AIxplorerbio Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 144. AIxplorerbio Recent Development
Table 145. Moore Threads Company Details
Table 146. Moore Threads Business Overview
Table 147. Moore Threads Drug Discovery Biosimulation Software Product
Table 148. Moore Threads Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 149. Moore Threads Recent Development
Table 150. StoneWise Company Details
Table 151. StoneWise Business Overview
Table 152. StoneWise Drug Discovery Biosimulation Software Product
Table 153. StoneWise Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 154. StoneWise Recent Development
Table 155. NovaX Biotech Company Details
Table 156. NovaX Biotech Business Overview
Table 157. NovaX Biotech Drug Discovery Biosimulation Software Product
Table 158. NovaX Biotech Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)
Table 159. NovaX Biotech Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 163. Authors List of This Report
List of Figures
Figure 1. Drug Discovery Biosimulation Software Picture
Figure 2. Global Drug Discovery Biosimulation Software Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Discovery Biosimulation Software Market Share by Type: 2024 VS 2031
Figure 4. Molecular Modeling And Structural Prediction Software Features
Figure 5. Virtual Screening And Molecular Design Software Features
Figure 6. ADMET Prediction Software Features
Figure 7. Molecular Dynamics Simulation Software Features
Figure 8. Systems Biology And Multiscale Modeling Software Features
Figure 9. Others Features
Figure 10. Global Drug Discovery Biosimulation Software Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Drug Discovery Biosimulation Software Market Share by Application: 2024 VS 2031
Figure 12. Target Recognition Case Studies
Figure 13. Virtual Screening Case Studies
Figure 14. Lead Optimization Case Studies
Figure 15. Pharmacokinetic Simulation Case Studies
Figure 16. Toxic Predicting Case Studies
Figure 17. Mechanism Analysis Case Studies
Figure 18. Effect Analysis Case Studies
Figure 19. Others Case Studies
Figure 20. Drug Discovery Biosimulation Software Report Years Considered
Figure 21. Global Drug Discovery Biosimulation Software Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Drug Discovery Biosimulation Software Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Drug Discovery Biosimulation Software Market Share by Region: 2024 VS 2031
Figure 24. Global Drug Discovery Biosimulation Software Market Share by Players in 2024
Figure 25. Global Drug Discovery Biosimulation Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Drug Discovery Biosimulation Software Revenue in 2024
Figure 27. North America Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Drug Discovery Biosimulation Software Market Share by Country (2020-2031)
Figure 29. United States Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Drug Discovery Biosimulation Software Market Share by Country (2020-2031)
Figure 33. Germany Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Drug Discovery Biosimulation Software Market Share by Region (2020-2031)
Figure 41. China Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Drug Discovery Biosimulation Software Market Share by Country (2020-2031)
Figure 49. Mexico Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Drug Discovery Biosimulation Software Market Share by Country (2020-2031)
Figure 53. Turkey Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Biolauncher Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 58. Dassault Systemes Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 60. Schrodinger Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 61. AstraZeneca Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 62. Insilico Medicine Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 63. Simulations Plus Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 64. Molecular Networks Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 65. Evotec Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 67. Certara Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 68. Tencent AI Lab Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 69. PharmaResources Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 70. Quantum Hi-Tech (China) Biotechnology Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 71. Leto Laboratories Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 72. Zuoshouyisheng Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 73. Taimei Technology Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 74. AIxplorerbio Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 75. Moore Threads Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 76. StoneWise Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 77. NovaX Biotech Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
